Renee P Tannenbaum is of Cardiff Oncology, Inc.. Currently has a direct ownership of 20,000 shares of CRDF, which is worth approximately $80,600. The most recent transaction as insider was on Dec 12, 2024, when has been sold 10,000 shares (Common Stock) at a price of $3.42 per share, resulting in proceeds of $34,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20K
100.0% 3M change
100.0% 12M change
Total Value Held $80,600

RENEE P TANNENBAUM Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 12 2024
BUY
Open market or private purchase
$34,200 $3.42 p/Share
10,000 Added 33.33%
20,000 Common Stock
Sep 15 2022
BUY
Open market or private purchase
$17,200 $1.72 p/Share
10,000 Added 50.0%
10,000 Common Stock

Also insider at

ZGNX
ZOGENIX, INC.
ANIP
ANI PHARMACEUTICALS INC Healthcare
RPT

Renee P Tannenbaum

San Diego, CA

Track Institutional and Insider Activities on CRDF

Follow Cardiff Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRDF shares.

Notify only if

Insider Trading

Get notified when an Cardiff Oncology, Inc. insider buys or sells CRDF shares.

Notify only if

News

Receive news related to Cardiff Oncology, Inc.

Track Activities on CRDF